| 中文別名： |
2-[[[3-甲基-4-(2,2,2三氟乙氧基)-2-吡啶]-甲基]硫基]-1H-苯并咪唑;2-[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶]甲基硫基-1H-苯并咪唑;2-[3-甲基-4-(2,2,2-三氟乙氧基)-2-哌啶基]甲基硫代-1H-苯并咪唑;蘭索拉唑硫化物;右旋蘭索拉唑雜質(zhì)C;2-[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基甲基硫]苯并咪唑;2-(3-溴芐基)氧基苯甲醛;2-[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶]甲基硫基;2-[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基甲基硫代]-1H-苯并咪唑;格列吡嗪雜質(zhì)B;蘭索拉唑;蘭索拉唑EP雜質(zhì)C;蘭索拉唑硫化物標(biāo)準(zhǔn)品;蘭索拉唑硫醚;蘭索拉唑雜質(zhì)B;蘭索拉唑雜質(zhì)B USP標(biāo)準(zhǔn)品;蘭索拉唑雜質(zhì)C(EP) 標(biāo)準(zhǔn)品;蘭索拉唑中間體;蘭索拉唑中間體4;硫化蘭索拉唑;蘭唑縮合物;2-[-[(3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶基)甲基]巰基]苯并咪唑;2-[3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶]甲基硫基-1H-苯并咪;2-3-甲基-4-(2,2,2-三氟乙氧基)-2-吡啶甲基硫基-1H-苯并咪唑;南索拉唑雜質(zhì)B;蘭索拉唑雜質(zhì)C;蘭索拉唑縮合物;蘭索拉唑雜質(zhì) 3;蘭索拉唑相關(guān)物質(zhì)B;蘭索拉唑硫醚(雜質(zhì)C);蘭索拉唑雜質(zhì)C（磺化物）;3-甲基-5-芐氧基-2-(4-芐氧基苯基)-1H-吲哚;7-氯-2-氧代庚酸乙酯;4-氯-2,3,5-三甲基吡啶-1-氧化物 |
| 英文別名： |
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole;2-[3-Methyl-4(2,2,2-trifluoroethoxy)pyrid-2yl]-Methylthio]benzimidazole;LANSOPRAZOLE SULFIDE;2-[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL]METHYL THIO-1H-BENZIMIDAZOLE;2-[[3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRID-2YL]METHYLTHIO]BENZIMIDAZOLE;2-((METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDINYL)THIO)-1H-BINZIMIDAZOLE;2-[[(3-Methyl-4-(2,2,2-Trifluoroethoxy) Pyridinyl) Methyl] Thio]-1H-Benzimidazole;2-[[[3-Methyl-4-(2,2,2-Trifluoroethyoxy)-2-Pyridyl]-Methyl]Thio]-1H-Benzimidazole;2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridinyl)thio)-(1H)-binzimidazole;Lansoprazole sulphide compound;3-Methyl-4-[((2,2,2-trifluroethoxy-2-pyridinyl)methyl)thio]-1H-benzimidazole;2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylthio]-1H-benzimidazole;2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylthio]benzimidazole;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]thio]benzimidazole;2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]thio]-1H-benzimidazole;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl]sulfanyl]-1H-benzimidazole;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1H-benzimidazole;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]thio]-1H-benzimidazole;AG1777;K 1252;lansoprazole sulphide;Lansoprazole impurity C;Lansoprazole EP IMpurity C;H 225;2-[[(3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDINYL)METHYL]THIO]-1H-BENZIMIDAZOLE;2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfanyl]-1H-benzimidazole;Q-200222;2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethylsulfanyl]-1H-benzoimidazole;2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]-methyl]thio]-1H-benzimidazole;CS-W013902;2-[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl]methylthio]benzimidazole;UNII-58XP950E2T;Lansoprazole Imp. C (EP); Lansoprazole USP Related Compound B; Lansoprazole USP RC B; 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulphanyl]-1H-benzimidazole; Lansoprazole Related Compound B; Lansoprazole Impurity C;HMS2365G10;FT-0631026;Lansoprazole impurity C [EP];2-((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methylthio)-1H-benzo[d]imidazole;SCHEMBL106519;2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]benzimidazole;2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]-methyl]thio]benzimidazole;AKOS000676433;2-([3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]-methyl)thio-1H-benzimidazole;AG 1777;C16H14F3N3OS;AC-1232;2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylthio]-1H-benzimidazole;F19518;DTXSID60145906;AG-1777;BCP12346;103577-40-8;2-(3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methylthio-1h-benzimidazole;58XP950E2T;2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]thio]-1h-benzimidazol;LANSOPRAZOLE SULPHIDE COMPOUND;2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl ]methyl... |
滬公網(wǎng)安備31011402010658號 
